Howe & Rusling Inc Viatris Inc Transaction History

Howe & Rusling Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $3,544 - $4,652	418 Added 35.36%	1,600 $14,000
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $308 - $380	31 Added 2.69%	1,182 $12,000
Q1 2022 May 10, 2022	BUY	$9.81 - $15.4 $88 - $138	9 Added 0.79%	1,151 $13,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $84 - $102	7 Added 0.62%	1,142 $15,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $795 - $907	-60 Reduced 5.02%	1,135 $15,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $259 - $323	-20 Reduced 1.65%	1,195 $17,000
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $9,893 - $13,497	-728 Reduced 37.47%	1,215 $17,000
Q4 2020 Feb 08, 2021	BUY	$14.3 - $18.74 $27,784 - $36,411	1,943 New	1,943 $36,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.